vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Kennedy-Wilson Holdings, Inc. (KW). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $120.6M, roughly 1.5× Kennedy-Wilson Holdings, Inc.). Kennedy-Wilson Holdings, Inc. runs the higher net margin — 48.1% vs 0.9%, a 47.2% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -11.0%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-55.2M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -6.0%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Kennedy Wilson is a real estate investment company headquartered in Beverly Hills, California, United States.
FOLD vs KW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $120.6M |
| Net Profit | $1.7M | $58.0M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 57.3% |
| Net Margin | 0.9% | 48.1% |
| Revenue YoY | 23.7% | -11.0% |
| Net Profit YoY | -88.5% | 32.7% |
| EPS (diluted) | $0.00 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $120.6M | ||
| Q3 25 | $169.1M | $116.4M | ||
| Q2 25 | $154.7M | $135.7M | ||
| Q1 25 | $125.2M | $128.3M | ||
| Q4 24 | $149.7M | $135.5M | ||
| Q3 24 | $141.5M | $127.5M | ||
| Q2 24 | $126.7M | $132.0M | ||
| Q1 24 | $110.4M | $136.4M |
| Q4 25 | $1.7M | $58.0M | ||
| Q3 25 | $17.3M | $-10.2M | ||
| Q2 25 | $-24.4M | $5.6M | ||
| Q1 25 | $-21.7M | $-29.6M | ||
| Q4 24 | $14.7M | $43.7M | ||
| Q3 24 | $-6.7M | $-66.8M | ||
| Q2 24 | $-15.7M | $-48.3M | ||
| Q1 24 | $-48.4M | $37.7M |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | 57.3% | ||
| Q3 25 | 20.3% | -6.2% | ||
| Q2 25 | -6.1% | 7.4% | ||
| Q1 25 | -6.3% | -26.9% | ||
| Q4 24 | 10.7% | 36.7% | ||
| Q3 24 | 15.3% | -60.8% | ||
| Q2 24 | 11.8% | -45.5% | ||
| Q1 24 | -25.1% | 47.2% |
| Q4 25 | 0.9% | 48.1% | ||
| Q3 25 | 10.2% | -8.8% | ||
| Q2 25 | -15.8% | 4.1% | ||
| Q1 25 | -17.3% | -23.1% | ||
| Q4 24 | 9.8% | 32.3% | ||
| Q3 24 | -4.8% | -52.4% | ||
| Q2 24 | -12.4% | -36.6% | ||
| Q1 24 | -43.9% | 27.6% |
| Q4 25 | $0.00 | $0.22 | ||
| Q3 25 | $0.06 | $-0.15 | ||
| Q2 25 | $-0.08 | $-0.05 | ||
| Q1 25 | $-0.07 | $-0.30 | ||
| Q4 24 | $0.05 | $0.24 | ||
| Q3 24 | $-0.02 | $-0.56 | ||
| Q2 24 | $-0.05 | $-0.43 | ||
| Q1 24 | $-0.16 | $0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $184.5M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $1.5B |
| Total Assets | $949.9M | $6.6B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $184.5M | ||
| Q3 25 | $263.8M | $382.6M | ||
| Q2 25 | $231.0M | $309.1M | ||
| Q1 25 | $250.6M | $356.6M | ||
| Q4 24 | $249.9M | $217.5M | ||
| Q3 24 | $249.8M | $367.1M | ||
| Q2 24 | $260.1M | $366.5M | ||
| Q1 24 | $239.6M | $541.9M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $1.5B | ||
| Q3 25 | $230.4M | $1.5B | ||
| Q2 25 | $204.3M | $1.6B | ||
| Q1 25 | $193.6M | $1.6B | ||
| Q4 24 | $194.0M | $1.6B | ||
| Q3 24 | $178.8M | $1.6B | ||
| Q2 24 | $132.5M | $1.7B | ||
| Q1 24 | $130.7M | $1.7B |
| Q4 25 | $949.9M | $6.6B | ||
| Q3 25 | $868.8M | $6.7B | ||
| Q2 25 | $815.3M | $6.8B | ||
| Q1 25 | $789.8M | $7.2B | ||
| Q4 24 | $785.0M | $7.0B | ||
| Q3 24 | $786.6M | $7.4B | ||
| Q2 24 | $749.5M | $7.5B | ||
| Q1 24 | $721.8M | $7.7B |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $11.4M |
| Free Cash FlowOCF − Capex | $16.0M | $-55.2M |
| FCF MarginFCF / Revenue | 8.6% | -45.8% |
| Capex IntensityCapex / Revenue | 0.2% | 55.2% |
| Cash ConversionOCF / Net Profit | 9.62× | 0.20× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $-103.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $11.4M | ||
| Q3 25 | $35.7M | $-7.6M | ||
| Q2 25 | $-26.5M | $42.0M | ||
| Q1 25 | $7.8M | $-51.9M | ||
| Q4 24 | $-3.9M | $55.1M | ||
| Q3 24 | $-23.0M | $-5.6M | ||
| Q2 24 | $22.7M | $36.7M | ||
| Q1 24 | $-29.7M | $-5.6M |
| Q4 25 | $16.0M | $-55.2M | ||
| Q3 25 | $35.3M | $-18.0M | ||
| Q2 25 | $-28.9M | $29.4M | ||
| Q1 25 | $7.5M | $-59.7M | ||
| Q4 24 | $-4.2M | $-76.5M | ||
| Q3 24 | $-23.3M | $-27.7M | ||
| Q2 24 | $21.6M | $-500.0K | ||
| Q1 24 | $-31.5M | $-57.1M |
| Q4 25 | 8.6% | -45.8% | ||
| Q3 25 | 20.9% | -15.5% | ||
| Q2 25 | -18.7% | 21.7% | ||
| Q1 25 | 6.0% | -46.5% | ||
| Q4 24 | -2.8% | -56.5% | ||
| Q3 24 | -16.5% | -21.7% | ||
| Q2 24 | 17.0% | -0.4% | ||
| Q1 24 | -28.5% | -41.9% |
| Q4 25 | 0.2% | 55.2% | ||
| Q3 25 | 0.2% | 8.9% | ||
| Q2 25 | 1.6% | 9.3% | ||
| Q1 25 | 0.2% | 6.1% | ||
| Q4 24 | 0.2% | 97.1% | ||
| Q3 24 | 0.3% | 17.3% | ||
| Q2 24 | 0.9% | 28.2% | ||
| Q1 24 | 1.6% | 37.8% |
| Q4 25 | 9.62× | 0.20× | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | 7.50× | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | 1.26× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
